Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Canopy Growth Corporation - Common Shares (NQ:CGC)

1.830 -0.100 (-5.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Canopy Growth Corporation - Common Shares

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
80 81 Next >
Marijuana Stock Movers For February 21, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From February 20, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
It’s Time! 3 Overhyped Cannabis Stocks to Sell in February.
These cannabis stocks are overhyped, so avoid them at all costs. They are badly placed at current prices and will drag down your portfolio. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Canopy Growth Earnings Preview
Via Benzinga
The Canadian Cannabis Report - Monday, Feb. 19
The past, present and future of the Canadian cannabis sector based on the performance of the MCCI, which is a proprietort index of 14 stocks. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Do Canopy Growth's Improved Q3 Numbers Give Investors Hope for a Turnaround?
Canopy Growth's financials do appear to be going in the right direction, but is that enough for investors? 
Via The Motley Fool
3 Poor Quarterly Financials Sink Cannabis LP Index
Our Cannabis LP Stocks Index continues to decline - down 61% in 2021, down 71% in 2022, down 65% in 2023. And it's already down 6% so far in 2024. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Bullish Friday For Marijuana Stocks - ESCO Technologies, Maple Leaf Green World Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Exit Now! 7 Nasdaq Stocks to Sell in February 2024.
Investors should stay away from these NASDAQ stocks to sell. All are facing significant challenges with a share price in decline. 
Via InvestorPlace
California's Proposed Cannabis Bill: Learn How This Controversial Legislation Could Revolutionize The States' Industry
Explore how California's AB 2223 could revolutionize the cannabis and hemp industries, impacting laws, products, and companies. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From February 13, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Fen. 12
The past, present, and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietory index of 14 stocks. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
From Underweight To Under Scrutiny: Can Canopy Growth Turn The Tide? Piper Sandler's Forecast On The Weed Giant
Could Canopy Growth Corporation (NASDAQ: CGC) be on the brink of turning its fortunes around, or is the optimism premature? 
Via Benzinga
Marijuana Stock Movers For February 12, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Q3 Financials Drive Canopy Growth Stock Down Further: Now -26% YTD
Q3 results demonstrate improved profitability and reduction in cash burn with the business delivering profitability improvements as well as sequential growth reinforcing their confidence in realizing a... 
Via Talk Markets
Exit Now! 3 Cannabis Stocks to Sell in February 2024
Amid regulatory uncertainties and presidential pardons, here are three cannabis stocks to sell in February to optimize your portfolio. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Cannabis LPs This Week: Canopy Growth Plummets, Organigram Surges
For the most part, our five largest Canadian Cannabis LPs are continuing the downward trend. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
420 with CNW — Texas AG Wants Court to Reverse Cannabis Decriminalization in Five Cities
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Canopy Growth (CGC) Q3 2024 Earnings Call Transcript
CGC earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Canopy Growth Reports 7% YoY Drop In Q3 Revenue, CEO Touts 'New Era' For Company As It Seeks US Listing
Canopy Growth reported an 81% YoY increase in "rest-of-world" cannabis revenue for Q3 2024. The company attributed the growth to strong performance in Australia and a return to growth in Europe. Canopy... 
Via Benzinga
Topics Cannabis Regulatory Compliance
Exposures Cannabis Legal Regulatory
Earnings Scheduled For February 9, 2024
Companies Reporting Before The Bell • TELUS (NYSE:TU) is expected to report quarterly earnings at $0.23 per share on revenue of $5.24 billion. 
Via Benzinga
Bullish Thursday For Marijuana Stocks - ESCO Technologies, Global Hemp Group Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
NYC's Film Hub Welcomes Freshly Baked NYC Weed Delivery, Now Serving Manhattan & Brooklyn
Long Island City (LIC), home to the legendary Silvercup Studios and known as a bustling hub for film and television production in New York City, is now entering a new era with the introduction of... 
Via Benzinga
3 Doomed Meme Stocks to Dump Before They Dive: February 2024
Investors would be smart to stay far away from these doomed meme stocks, each of which has poor finances and a questionable future. 
Via InvestorPlace
Cannabis Stock Movers For February 7, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From February 5, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
If You Invested $5,000 in Green Thumb Industries in 2019, This Is How Much You Would Have Today
Green Thumb Industries has been one of the best-performing pot stocks over the past five years. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For February 2, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For February 1, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Top Canadian Cannabis Producers Caught In International Controversy Over Imports
Israel's Trade Levies Unit launched an anti-dumping investigation into the import of medical cannabis from Canada, saying it causes injury to the domestic cannabis industry in Israel. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
80 81 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.